Extera Partners invests in existing life science companies and builds new ones by leveraging unique deal flow, a team of industry leaders, its own financing resources, and a close network of family offices and institutional investors. Since its inception in 2007 as a corporate development advisory firm, Extera has generated substantial financial returns for investors through strategic transactions and public listings
Our
Team
Investments & Venture Creation
Investing in and creating biotechnology and medical device ventures aimed at improving clinical outcomes, enhancing quality of life, and reducing healthcare costs.
Transactions
Transactions we managed as executives within our portfolio companies, as well as those we oversaw as consultants to other firms through our former corporate development advisory practice.
Private Placement
Undisclosed
Acquisition
$83,000,000
Collaboration
$500,000,000
Collaboration
$350,000,000
Private Placement
Undisclosed
Private Placement
Undisclosed
Acquisition
Undisclosed
Acquisition
$93,000,000
Collaboration
Undisclosed
Licensing
$75,000,000
Private Placement
$28,000,000
Licensing
$8,000,000
Collaboration
Undisclosed
Collaboration
Undisclosed
Collaboration
Undisclosed
Acquisition
$300,000,000
Acquisition
$250,000,000
Funding & Distribution
$5,000,000
Collaboration
Undisclosed
Private Placement
$8,000,000
Distribution
Undisclosed
Distribution
Undisclosed
Private Placement
$21,000,000
Private Placement
Undisclosed
Asset Sales
$200,000,000
Acquisition
$130,000,000
Licensing
$58,000,000
Research Collaboration
$300,000,000
Acquisition
$59,000,000
Private Placement
$12,000,000
Equity Investment
Undisclosed
Equity Investment
Undisclosed
Licensing
$95,000,000
Reverse Take Over
$65,000,000
Acquisition
$500,000,000
Option to Buy Agreement
$35,000,000
Series A Financing
Undisclosed
Product Line Acquisition
Undisclosed
Acquisition
$200,000,000
© Extera Partners, 2025